Previous studies in models of dilated cardiomyopathy caused by LMNA gene mutations have shown sarcomeric organization defects associated with abnormal activation of the Cofilin 1, ERK1/2, and p38α pathways in the heart.29–31. The gene discussed is MAPK3; the disease is dilated cardiomyopathy.